Cargando…

Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment

Markers of JC polyomavirus (JCPyV) activity can be used to evaluate the risk of progressive multifocal leukoencephalopathy (PML) in treated multiple sclerosis (MS) patients. The presence of JCPyV DNA and microRNA (miR-J1-5p), the anti-JCV index and the sequence of the non-coding control region (NCCR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prezioso, Carla, Ciotti, Marco, Brazzini, Gabriele, Piacentini, Francesca, Passerini, Sara, Grimaldi, Alfonso, Landi, Doriana, Nicoletti, Carolina Gabri, Zingaropoli, Maria Antonella, Iannetta, Marco, Altieri, Marta, Conte, Antonella, Limongi, Dolores, Marfia, Girolama Alessandra, Ciardi, Maria Rosa, Mastroianni, Claudio Maria, Palamara, Anna Teresa, Moens, Ugo, Pietropaolo, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781243/ https://www.ncbi.nlm.nih.gov/pubmed/35054041 http://dx.doi.org/10.3390/jcm11020347

Ejemplares similares

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment
por: Prezioso, Carla, et al.
Publicado: (2021)

JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus
por: Zingaropoli, Maria A., et al.
Publicado: (2018)

Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment
por: Pietropaolo, Valeria, et al.
Publicado: (2015)

Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study
por: Rodio, Donatella Maria, et al.
Publicado: (2016)

JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis
por: Ciardi, Maria Rosa, et al.
Publicado: (2020)

Prevalence of MCPyV, HPyV6, HPyV7 and TSPyV in Actinic Keratosis Biopsy Specimens
por: Prezioso, Carla, et al.
Publicado: (2022)

COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains
por: Prezioso, Carla, et al.
Publicado: (2022)

Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients
por: Iannetta, Marco, et al.
Publicado: (2019)

HIV Viremia Is Associated With APOL1 Variants and Reduced JC-Viruria
por: Kruzel-Davila, Etty, et al.
Publicado: (2021)

B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications
por: Iannetta, Marco, et al.
Publicado: (2022)

Outcomes of Living Kidney Donor Candidates and Living Kidney Recipient Candidates with JC Polyomavirus and BK Polyomavirus Viruria
por: Querido, Sara, et al.
Publicado: (2021)

IV immunoglobulin confounds JC virus antibody serostatus determination
por: Kister, Ilya, et al.
Publicado: (2014)

Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without kidney dysfunction
por: Taheri, Shahram, et al.
Publicado: (2011)

Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection
por: Prezioso, Carla, et al.
Publicado: (2017)

Detection of Merkel Cell Polyomavirus (MCPyV) DNA and Transcripts in Merkel Cell Carcinoma (MCC)
por: Passerini, Sara, et al.
Publicado: (2023)

HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity
por: Iannetta, Marco, et al.
Publicado: (2013)

Reply to Henriksen, S.; Rinaldo, C.H. Should SVGp12 Be Used for JC Polyomavirus Studies? Comment on “Prezioso et al. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains. Viruses 2022, 14, 2070”
por: Prezioso, Carla, et al.
Publicado: (2022)

Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients
por: D’Abramo, Alessandra, et al.
Publicado: (2016)

Structural Analysis of Merkel Cell Polyomavirus (MCPyV) Viral Capsid Protein 1 (VP1) in HIV-1 Infected Individuals
por: Prezioso, Carla, et al.
Publicado: (2020)

Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation
por: Iannetta, Marco, et al.
Publicado: (2016)

Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023)

New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy
por: Bellizzi, Anna, et al.
Publicado: (2013)

The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia
por: Ciardi, Maria Rosa, et al.
Publicado: (2020)

Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2022)

Detection Analysis and Study of Genomic Region Variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the Urine and Plasma of HIV-1-Infected Patients
por: Passerini, Sara, et al.
Publicado: (2022)

Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
por: D'Abramo, Alessandra, et al.
Publicado: (2014)

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2021)

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis
por: Ciardi, Maria R, et al.
Publicado: (2018)

Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis
por: Landi, Doriana, et al.
Publicado: (2020)

A Case of BK Nephropathy without Detectable Viremia or Viruria
por: Kamel, Mahmoud, et al.
Publicado: (2015)

Regulation of Transcriptional Activity of Merkel Cell Polyomavirus Large T-Antigen by PKA-Mediated Phosphorylation
por: Falquet, Mar, et al.
Publicado: (2023)

Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis
por: Ziccardi, Lucia, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

The DNA damage response promotes polyomavirus JC infection by nucleus to cytoplasm NF- kappaB activation
por: White, Martyn K., et al.
Publicado: (2017)

Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
por: Iannetta, Marco, et al.
Publicado: (2020)

Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod
por: Barbano, Lucilla, et al.
Publicado: (2021)

Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells’ Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration
por: Barbano, Lucilla, et al.
Publicado: (2022)

Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey
por: Landi, Doriana, et al.
Publicado: (2021)

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease
por: Fedele, Giorgio, et al.
Publicado: (2022)

Polyomaviruses and disease: is there more to know than viremia and viruria?
por: Nickeleit, Volker, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k3o5g5hvonlj2mk1vk0s2rjith